1 Market Overview
1.1 Neuromuscular Blocking Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuromuscular Blocking Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Non-polarizing Agents
1.2.3 Depolarizing Agents
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuromuscular Blocking Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Overview of Global Neuromuscular Blocking Drug Market
1.4.1 Global Neuromuscular Blocking Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hikma Pharmaceuticals
2.1.1 Hikma Pharmaceuticals Details
2.1.2 Hikma Pharmaceuticals Major Business
2.1.3 Hikma Pharmaceuticals SWOT Analysis
2.1.4 Hikma Pharmaceuticals Product and Services
2.1.5 Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Product and Services
2.6.4 AbbVie Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Product and Services
2.7.4 Pfizer Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neuromuscular Blocking Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neuromuscular Blocking Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuromuscular Blocking Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Neuromuscular Blocking Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neuromuscular Blocking Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Neuromuscular Blocking Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neuromuscular Blocking Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.3 Europe Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.5 South America Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
5.1.1 North America Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
5.3 Canada Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.3 UK Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.4 France Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.5 Russia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.6 Italy Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neuromuscular Blocking Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neuromuscular Blocking Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neuromuscular Blocking Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.3 Japan Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.4 Korea Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.5 India Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.7 Australia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
8.1.1 South America Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neuromuscular Blocking Drug Sales and Market Share by Type (2015-2020)
10.2 Global Neuromuscular Blocking Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Neuromuscular Blocking Drug Price by Type (2015-2020)
11 Global Neuromuscular Blocking Drug Market Segment by Application
11.1 Global Neuromuscular Blocking Drug Sales Market Share by Application (2015-2020)
11.2 Global Neuromuscular Blocking Drug Revenue Market Share by Application (2015-2020)
11.3 Global Neuromuscular Blocking Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neuromuscular Blocking Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Neuromuscular Blocking Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.2 Europe Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.4 South America Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.3 Neuromuscular Blocking Drug Market Forecast by Type (2021-2025)
12.3.1 Global Neuromuscular Blocking Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Neuromuscular Blocking Drug Market Share Forecast by Type (2021-2025)
12.4 Neuromuscular Blocking Drug Market Forecast by Application (2021-2025)
12.4.1 Global Neuromuscular Blocking Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Neuromuscular Blocking Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【掲載企業】
Hikma Pharmaceuticals、Bayer、Merck、GSK、Novartis、AbbVie、Pfizer
【免責事項】
https://www.globalresearch.jp/disclaimer